TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

IsraelRecruitingPHASE3

Conditions

Transthyretin Amyloidosis With Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Clinical Trial Site, La Jolla, California, United States

  • Clinical Trial Site, Stanford, California, United States

  • Clinical Trial Site, Norwich, Connecticut, United States

  • Clinical Trial Site, Washington D.C., District of Columbia, United States

  • Clinical Trial Site, Brandon, Florida, United States

  • Clinical Trial Site, Miami, Florida, United States

  • Clinical Trial Site, Atlanta, Georgia, United States

  • Clinical Trial Site, Gainesville, Georgia, United States

  • Clinical Trial Site, Tucker, Georgia, United States

  • Clinical Trial Site, Evanston, Illinois, United States

  • Clinical Trial Site, Indianapolis, Indiana, United States

  • Clinical Trial Site, Indianapolis, Indiana, United States

  • Clinical Trial Site, Kansas City, Kansas, United States

  • Clinical Trial Site, Baltimore, Maryland, United States

  • Clinical Trial Site, Boston, Massachusetts, United States

  • Clinical Trial Site, Boston, Massachusetts, United States

  • Clinical Trial Site, Detroit, Michigan, United States

  • Clinical Trial Site, Rochester, Minnesota, United States

  • Clinical Trial Site, St Louis, Missouri, United States

  • Clinical Trial Site, Manhasset, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, The Bronx, New York, United States

  • Clinical Trial Site, Charlotte, North Carolina, United States

  • Clinical Trial Site, Cleveland, Ohio, United States

  • Clinical Trial Site, Portland, Oregon, United States

  • Clinical Trial Site, Lancaster, Pennsylvania, United States

  • Clinical Trial Site, Philadelphia, Pennsylvania, United States

  • Clinical Trial Site, Charleston, South Carolina, United States

  • Clinical Trial Site, Dallas, Texas, United States

  • Clinical Trial Site, Houston, Texas, United States

  • Clinical Trial Site, Plano, Texas, United States

  • Clinical Trial Site, Salt Lake City, Utah, United States

  • Clinical Trial Site, Charlottesville, Virginia, United States

  • Clinical Trial Site, Falls Church, Virginia, United States

  • Clinical Trial Site, Norfolk, Virginia, United States

  • Clinical Trial Site, Richmond, Virginia, United States

  • Clinical Trial Site, Spokane, Washington, United States

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Rosario, Argentina

  • Clinical Trial Site, Rosario, Argentina

  • Clinical Trial Site, Rosario, Argentina

  • Clinical Trial Site, Adelaide, Australia

  • Clinical Trial Site, Bedford Park, Australia

  • Clinical Trial Site, Box Hill, Australia

  • Clinical Trial Site, Chermside, Australia

  • Clinical Trial Site, Darlinghurst, Australia

  • Clinical Trial Site, Joondalup, Australia

  • Clinical Trial Site, Westmead, Australia

  • Clinical Trial Site, Braunau am Inn, Austria

  • Clinical Trial Site, Graz, Austria

  • Clinical Trial Site, Vienna, Austria

  • Clinical Trial Site, Vienna, Austria

  • Clinical Trial Site, Vienna, Austria

  • Clinical Trial Site, Wels, Austria

  • Clinical Trial Site, Aalst, Belgium

  • Clinical Trial Site, Bruges, Belgium

  • Clinical Trial Site, Brussels, Belgium

  • Clinical Trial Site, Dendermonde, Belgium

  • Clinical Trial Site, Genk, Belgium

  • Clinical Trial Site, Ghent, Belgium

  • Clinical Trial Site, Hasselt, Belgium

  • Clinical Trial Site, Leuven, Belgium

  • Clinical Trial Site, Liège, Belgium

  • Clinical Trial Site, Roeselare, Belgium

  • Clinical Trial Site, Belo Horizonte, Brazil

  • Clinical Trial Site, Porto Alegre, Brazil

  • Clinical Trial Site, Porto Alegre, Brazil

  • Clinical Trial Site, Ribeirão Preto, Brazil

  • Clinical Trial Site, Ribeirão Preto, Brazil

  • Clinical Trial Site, Salvador, Brazil

  • Clinical Trial Site, São Paulo, Brazil

  • Clinical Trial Site, São Paulo, Brazil

  • Clinical Trial Site, Calgary, Canada

  • Clinical Trial Site, London, Canada

  • Clinical Trial Site, Santiago, Chile

  • Clinical Trial Site, Santiago, Chile

  • Clinical Trial Site, Dongcheng, China

  • Clinical Trial Site, Haidian, China

  • Clinical Trial Site, Brno, Czechia

  • Clinical Trial Site, Ostrava, Czechia

  • Clinical Trial Site, Prague, Czechia

  • Clinical Trial Site, Prague, Czechia

  • Clinical Trial Site, Aarhus N, Denmark

  • Clinical Trial Site, København Ø, Denmark

  • Clinical Trial Site, Odense C, Denmark

  • Clinical Trial Site, Chambray-lès-Tours, France

  • Clinical Trial Site, Créteil, France

  • Clinical Trial Site, Dijon, France

  • Clinical Trial Site, La Tronche, France

  • Clinical Trial Site, Marseille, France

  • Clinical Trial Site, Martinique, France

  • Clinical Trial Site, Montpellier, France

  • Clinical Trial Site, Paris, France

  • Clinical Trial Site, Paris, France

  • Clinical Trial Site, Pessac, France

  • Clinical Trial Site, Reims, France

  • Clinical Trial Site, Rennes, France

  • Clinical Trial Site, Rouen, France

  • Clinical Trial Site, Saint-Herblain, France

  • Clinical Trial Site, Strasbourg, France

  • Clinical Trial Site, Toulouse, France

  • Clinical Trial Site, Berlin, Germany

  • Clinical Trial Site, Cologne, Germany

  • Clinical Trial Site, Göttingen, Germany

  • Clinical Trial Site, Hanover, Germany

  • Clinical Trial Site, Heidelberg, Germany

  • Clinical Trial Site, Leipzig, Germany

  • Clinical Trial Site, Magdeburg, Germany

  • Clinical Trial Site, Munich, Germany

  • Clinical Trial Site, Münster, Germany

  • Clinical Trial Site, Würzburg, Germany

  • Clinical Trial Site, Athens, Greece

  • Clinical Trial Site, Athens, Greece

  • Clinical Trial Site, Heraklion, Greece

  • Clinical Trial Site, Thessaloniki, Greece

  • Clinical Trial Site, Hong Kong, Hong Kong

  • Clinical Trial Site, Balatonfüred, Hungary

  • Clinical Trial Site, Budapest, Hungary

  • Clinical Trial Site, Be’er Ya‘aqov, Israel

  • Clinical Trial Site, Haifa, Israel

  • Clinical Trial Site, Jerusalem, Israel

  • Clinical Trial Site, Petah Tikva, Israel

  • Clinical Trial Site, Ancona, Italy

  • Clinical Trial Site, Bologna, Italy

  • Clinical Trial Site, Brescia, Italy

  • Clinical Trial Site, Florence, Italy

  • Clinical Trial Site, Forlì, Italy

  • Clinical Trial Site, Lecce, Italy

  • Clinical Trial Site, Milan, Italy

  • Clinical Trial Site, Naples, Italy

  • Clinical Trial Site, Padova, Italy

  • Clinical Trial Site, Pavia, Italy

  • Clinical Trial Site, Pisa, Italy

  • Clinical Trial Site, Rimini, Italy

  • Clinical Trial Site, Roma, Italy

  • Clinical Trial Site, Rome, Italy

  • Clinical Trial Site, Torino, Italy

  • Clinical Trial Site, Bunkyō City, Japan

  • Clinical Trial Site, Fukuoka, Japan

  • Clinical Trial Site, Fukuoka, Japan

  • Clinical Trial Site, Kagawa, Japan

  • Clinical Trial Site, Kashihara, Japan

  • Clinical Trial Site, Kobe, Japan

  • Clinical Trial Site, Kumamoto, Japan

  • Clinical Trial Site, Kurume, Japan

  • Clinical Trial Site, Matsumoto-shi, Japan

  • Clinical Trial Site, Nagoya, Japan

  • Clinical Trial Site, Nankoku, Japan

  • Clinical Trial Site, Niigata, Japan

  • Clinical Trial Site, Okayama, Japan

  • Clinical Trial Site, Sapporo, Japan

  • Clinical Trial Site, Sapporo, Japan

  • Clinical Trial Site, Sendai, Japan

  • Clinical Trial Site, Suita, Japan

  • Clinical Trial Site, Tokyo, Japan

  • Clinical Trial Site, Kajang, Malaysia

  • Clinical Trial Site, Kuala Lumpur, Malaysia

  • Clinical Trial Site, Eindhoven, Netherlands

  • Clinical Trial Site, Groningen, Netherlands

  • Clinical Trial Site, Maastricht, Netherlands

  • Clinical Trial Site, Rotterdam, Netherlands

  • Clinical Trial Site, Utrecht, Netherlands

  • Clinical Trial Site, Christchurch, New Zealand

  • Clinical Trial Site, Hamilton, New Zealand

  • Clinical Trial Site, Ålesund, Norway

  • Clinical Trial Site, Lørenskog, Norway

  • Clinical Trial Site, Carnaxide, Portugal

  • Clinical Trial Site, Creixomil, Portugal

  • Clinical Trial Site, Leiria, Portugal

  • Clinical Trial Site, Lisbon, Portugal

  • Clinical Trial Site, Lisbon, Portugal

  • Clinical Trial Site, Vila Real, Portugal

  • Clinical Trial Site, Viseu, Portugal

  • Clinical Trial Site, Bucharest, Romania

  • Clinical Trial Site, Cluj-Napoca, Romania

  • Clinical Trial Site, Košice, Slovakia

  • Clinical Trial Site, Incheon, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, A Coruña, Spain

  • Clinical Trial Site, Barcelona, Spain

  • Clinical Trial Site, Barcelona, Spain

  • Clinical Trial Site, Bilbao, Spain

  • Clinical Trial Site, El Palmar, Spain

  • Clinical Trial Site, Huelva, Spain

  • Clinical Trial Site, Jaén, Spain

  • Clinical Trial Site, L'Hospitalet de Llobregat, Spain

  • Clinical Trial Site, Lleida, Spain

  • Clinical Trial Site, Madrid, Spain

  • Clinical Trial Site, Madrid, Spain

  • Clinical Trial Site, Palma de Mallorca, Spain

  • Clinical Trial Site, Pamplona, Spain

  • Clinical Trial Site, Salamanca, Spain

  • Clinical Trial Site, Santiago de Compostela, Spain

  • Clinical Trial Site, Valencia, Spain

  • Clinical Trial Site, Valencia, Spain

  • Clinical Trial Site, Vigo, Spain

  • Clinical Trial Site, Gothenburg, Sweden

  • Clinical Trial Site, Lund, Sweden

  • Clinical Trial Site, Solna, Sweden

  • Clinical Trial Site, Basel, Switzerland

  • Clinical Trial Site, Geneva, Switzerland

  • Clinical Trial Site, Lucerne, Switzerland

  • Clinical Trial Site, Sankt Gallen, Switzerland

  • Clinical Trial Site, New Taipei City, Taiwan

  • Clinical Trial Site, Taichung, Taiwan

  • Clinical Trial Site, Taipei, Taiwan

  • Clinical Trial Site, Taipei, Taiwan

  • Clinical Trial Site, Antalya, Turkey (Türkiye)

  • Clinical Trial Site, Istanbul, Turkey (Türkiye)

  • Clinical Trial Site, Bellshill, United Kingdom

  • Clinical Trial Site, Birmingham, United Kingdom

  • Clinical Trial Site, Cardiff, United Kingdom

  • Clinical Trial Site, London, United Kingdom

  • Clinical Trial Site, London, United Kingdom

  • Clinical Trial Site, Manchester, United Kingdom

Study leads
  • Medical Director

    Study Director

    Alnylam Pharmaceuticals